InvestmentUpdated on 27 November 2024
dAIgnostics - AI supported neuroinflammatory disease early diagnostics
About
dAIgnostics' methodology for the early diagnosis of Amyotrophic Lateral Sclerosis, Parkinson’s disease, Alzheimer’s disease, and neuroinflammatory diseases is founded on 30 years of extensive research and experimentation, backed by €3.5M in research grants to date. Leveraging advanced AI algorithms, our solution facilitates population-wide screening for early disease detection in general healthcare settings and empowers pharmaceutical companies to develop early-stage treatments. This groundbreaking approach has the potential to improve the lives of millions globally while creating a significant new segment within the global pharmaceutical market.
We have assembled a regional multidisciplinary super-team of renowned scientists, seasoned business experts, and visionary angel investors. Join us on our journey to develop a Minimum Viable Product, setting the stage for a company poised to be valued at hundreds of millions of Euros!
Stage
- Seed and Development
Applies to
- Biotech, Pharma and Cosmetics
Similar opportunities
Investment
Digital wellness platform for women that combines self-care and fitness.
- Startup
- Healthcare
- Seed and Development
- Growth and Establishment
- ICT Industry and Services
Magdalena Bilić
Founder at Mrvicu sretnija/Just a lil' bit
Zagreb, Croatia
Partnership
Partner with Us: Transforming Access to Personal and Professional Development
Tesa Vitelj
Business Development Coach & Mentor, Leadership Development, Personal Transformation at Vitesa
Koprivnica, Croatia
Project cooperation
- Early
- Technical
- Financing
- Sales/Distribution
Valentina BAN
Self employed, start-up owner of Zdravi interijeri at Zdravi interijeri / Healthy interiors
Rijeka, Croatia